ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Cost of revenue

Fuso Pharmaceutical Industries,Ltd. (4538)

Market cap
¥19.6B
P/E ratio
13.6x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 202646,312+5.18%
Mar 31, 202544,030+5.92%
Mar 31, 202441,568+11.52%
Mar 31, 202337,275+2.87%
Mar 31, 202236,235+3.11%
Mar 31, 202135,142+3.05%
Mar 31, 202034,101+4.46%
Mar 31, 201932,644+0.04%
Mar 31, 201832,630-2.69%
Mar 31, 201733,532+0.99%
Mar 31, 201633,202-2.48%
Mar 31, 201534,046

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat